What is TuHURA Biosciences, Inc.'s return on equity?

TuHURA Biosciences, Inc. (HURA) reported return on equity of -187.2% in Q1 2026.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

TuHURA Biosciences, Inc. HURA Return on equity

Return on equity at other companies

Bristol-Myers SquibbBMY

38.8%+7.3pp

CTO

Citius Oncology, Inc.CTOR

-119.9%+46.7pp

Inhibrx Biosciences, Inc.INBX

-197.8%-2,158pp

Corvus PharmaceuticalsCRVS

-30.5%-12.5pp

Avalo TherapeuticsAVTX

-88.8%—

Janux TherapeuticsJANX

-11.7%+4.1pp

Other financials

Income statement

See full

Revenue-—

Net income-$7.5M-13.1%

EPS (diluted)-$0.13+13.3%

Balance sheet

See full

Cash & equivalents$6.3M+1.3%

Total debt$456.9K+178%

Total equity$23.2M+135%

Total assets$29.7M+103%

Cash flow

See full

Operating cash flow-$4.4M+6.9%

CapEx$48.8K+14.5%

Free cash flow-$4.5M+6.7%

Valuation

See full

Market cap$155.39M+45.8%

Enterprise value$149.54M+52.3%

Returns & leverage

See full

Debt / equity0×0.0×

Current ratio1.2×-1.8×

Where this comes from

Calculated from TuHURA Biosciences, Inc.’s reported figures.

net income/total stockholders equity=-187.2%

Based on trailing twelve months.

The official record: TuHURA Biosciences, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about TuHURA Biosciences, Inc.'s return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TuHURA Biosciences, Inc.'s return on equity?: TuHURA Biosciences, Inc. (HURA) reported return on equity of -187.2% in Q1 2026.
What does return on equity mean?: Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.